研究限制與未來發展之建議

不論是東方醫學的體質學說，或者是西方科學發展的代謝型態學 說，在發展的過程中皆融入其特有的民族文化與哲學思想。從邏輯觀念 探討，即使是不同的人種，因為都具有細胞代謝功能和體質狀況，所以 體質學說或代謝型態學說皆可以用來定義個體的體質生化狀況。舉例說 明，中醫診斷人體有寒熱性體質，是不分西方或東方人種，辨證論治。

體質屬寒者，以熱性食物或藥材溫補之；體質熱者，則以寒性食物或藥 材涼瀉之。代謝型態學說亦復如此，檢測出個體生化代謝屬快速氧化型 者，建議以高比例蛋白質Group II 飲食型態做為代謝平衡之調整，屬慢 速氧化型者，則建議以高比例醣類Group I 飲食型態做為代謝平衡之調 整，此學說並無人種之分。

惟當學說跨越種族期能彼此接受和運用時，是否仍需考量具有種族 性、飲食文化的特殊差異性。代謝型態學說的Group II 飲食型態，提出 蛋白質的比例為40%，醣類 30%及脂肪 30%為飲食主要內容，對於擁有 悠久米食文化的亞洲人種而言是否適合，目前並無足夠亞洲人種的數據 參考，未來應可以透過大型的試驗個案，建立適合我國民族的體質所需 飲食型態，並期能做為亞洲其他國家人民飲食攝取比例之建議參考。

第六章 結論

減重成效和遺傳因子、飲食運動生活型態、心理環境等因素息息相 關，飲食型態因素對減重者的影響最為重要，透過代謝型態的了解將有 助於強化減重者對飲食比例攝取的正確性，和執行減重計劃的動機。

對於體重控制者進入任何一種減重計劃前，透過代謝型態檢測，發現個 人對飲食的生化代謝狀態，攝取適合自己的飲食比例，吃對合適自己的 飲食是有必要的。

參考文獻

英文部份

Allred JB (1995) Too much of a good thing? An overemphasis on eating low-fat foods may be contributing to the alarming increase in overweight among us adults. JADA. 95: 417-418.

Atson G (1965) Differences in intermediary metabolism in mental illness.

Psychol Rep. 17:563-582.

Atkins RC (2001) Dr Atkins’ New Diet Revolution. New York: WholeCare/

Avon

Balkau B, Shipley M & Jarrett RJ (1998) High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study. Diabetes Care. 21:360-367.

Byrne NM, Weinsier RL, Hunter GR, Desmond R, Patterson MA, Darnell BE

& Zuckerman PA (2003) Influence of distribution of lean body mass on resting metabolic rate after weight loss and weight regain:

comparison of responses in white and black women. Am J Clin Nutr 77:1368-1373.

Bland JS & Sara HB (1999) Genetic nutritioneering. Los Angeles: Keats.

Boden G, Sarqrad K & Homko C (2005) Effect of a low-carbohydrate diet on appetite, blood glucose levels, and insulin resistance in obese patients with type 2 diabetes. Ann Intern Med. 142:403-411.

Busetto L, Sergi G, & Enzi G (2004) Short-term effects of weight loss on the cardiovascular risk factors in morbidly obese patients. Obes Res.

12:1256-1263.

Chan JM, Rimm EB, & Colditz GA (1994) Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care.

17:961-969.

Currier WD (1959) Intensive vitamin therapy in mental illness. Psychology.

49:67-81.

Metab. 8:629-660.

Despres JP (1993) Abdominal obesity as important component of insulin-resistance syndrome. Nutrition. 9:452-459.

Despres JP, Lamarche B, & Mauriege P (1996) Hyperinsulinism as an independent risk factor for ischemic heart disease. N Engl J Med.

334:952-957.

Despres JP, Moorjani S, & Lupien PJ (1990) Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis.

10:497-511.

Dumesnil JG, Turgeon J & Tremblay A (2001) Effect of a low-glycemic index-low fat-high protein diet on the atherogenic metabolic risk profile of abdominally obese men. Br. J Nutr. 86:557-568.

German JB, Hammock BD & Watkins SM (2005) Building on a century of biochemistry to guide human health. Metabolomics 1:3-9.

Gibbs WW. (2005) Obesity: An Overblown Epidemic? Scientific American pp.70-77.

Gonzalez NJ (2007) Seeking the truth in the fight against cancer. Altern Ther Health Med. 13:66-73.

Gonzalez NJ & Isaacs LL (1999) Evaluation of pancreatic proteolytic enzyme treatment of adenocarcinoma of the pancreas, with nutrition and detoxification support. Nutr Cancer. 33:117-124.

Grievink L, Alberts JF & O’Niel J (2004) Waist circumference as a

measurement of obesity in the Netherlands Antilles; associations with hypertension and diabetes mellitus. Eur J Clin Nutr. 58:1159-1165.

http://educate-yourself.org/cancer/kellysmetabolictherapy.shtml

Hattersly JG (1991) Acquired atherosclerosis: theories of causation novel therapies. J Orth Medicine 6:83-98.

Henry P, Thomas F & Benetos A (2002) Impaired fasting glucose, blood pressure and cardiovascular disease mortality. Hypertension.

40:458-463.

Imazu M (2002) Hypertension and insulin disorders. Curr Hypertens Rep.

4:477-482.

James OH (2005) Obesity treatment: does one size fit all? Am J Clin Nutr

Janssen I, Katzmarzyk PT & Ross R (2005) Body mass index is inversely related to mortality in older people after adjustment for waist circumference. J Am Geriatr Soc. 53:2112-2118.

Janssen I, Heymsfield SB & Allison DB (2002) Body mass index and waist circumference independently contribute to the prediction of

nonabdominal, abdominal subcutaneous, and visceral fat. Am J Clin Nutr. 75:683-688.

Kahn HS & Valdez R (2003) Metabolic risks identified by the combination of enlarged waist and elevated triacylglycerol concentration. Am J Clin Nutr. 78:902-903.

Kelley WD (1976) One answer to cancer—The metabolic types. Kelley Foundation.

Kim HK, Yamatodani A, Imamura K, Noguchi T & Tanaka T (1994) The role of the autonomic nervous system in the thermic effects of protein and carbohydrates in rats. J Nutr Sci Vitaminol (Tokyo).40:523-534.

Kristal HJ & Haig JM (2002) The Nutrition Solution. A Guide to Your Metabolic Type. Berkeley, California, North Atlantic Books Lejeune MP, Kovacs EM & Westerterp-Plantenga MS. (2005) Additional

protein intake limits weight regain after weight loss in humans. Br j Nutr. 93:281-289.

Leinonin E, hurt-Camejo E & Wiklund O (2003) Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell

adhesion molecules in type 2 diabetes. Atherosclerosis. 166:387-394.

Lemieux I, Pascot A & Couillard C (2000) Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia;

hyperapolipoprotein B; small, dense LDL) in men? Circulation.

102:179-184

Li Z, Hong K & Saltsman P (2005) Long-term efficacy of soy-based meal replacements vs an individualized diet plan in obese type II DM patients: relative effects on weight loss, metabolic parameters, and C-reactive protein. Eur J Clin Nutr. 59:411-418.

Maffiulett NA, Aqosti F & Marinone PG (2005) Changes in body

composition, physical performance and cardiovascular risk factors after a 3-week integrated body weight reduction program and after 1-y follow-up in severely obese men and women. Eur J Clin Nutr.

59:685-694.

Mudgins LC, Hellerstein MK & Seidamn CE (2000) Relationship between carbohydrate-induced hypertriglyceridemia and fatty acid synthesis in lean and obese subjects. J Lipid Res. 41:595-604.

Nacht CA, Chritin L, Temler E, Chiolero R, Jequier E & Acheson K J (1987) Thermic effect of food: Possible implication of parasympathetic nervous system. Am. J. Physiol. 253:E481-E488.

Noakes M, Keogh JB, Foster PR & Clifton PM (2005) Effect of an

energy-restricted, high-protein, low-fat diet relative to a conventional high-carbohydrate, low-fat diet on weight loss, body composition, nutritional status, and markers of cardiovascular health in obese women. Am J Clin Nutr 81:1298-1306.

Park HS & Lee K (2005) Greater beneficial effects of visceral fat reduction compared with subcutaneous fat reduction on parameters of the metabolic syndrome: a study of weight reduction programmes in subjects with visceral and subcutaneous obesity. Diabet Med.

22:266-272.

Pottenger FM (1919) Symptoms of visceral disease. C.V. Mosby Co.

Poynten AM, Markovic TP, Maclean EL, Furler SM, Freund J, Chisholm DJ

& Campbell LV (2003) Fat oxidation, body composition and insulin sensitivity in diabetic and normoglycaemic obese adults 5 years after weight loss. Int J Obes Relat Metab Disord. 27:1212-1218.

Roger W (1956) Biochemical Individuality. New York: Wiley and Sons, New Canaan, Connecticut: Keats Publishing.

Roger W (1971) Nutrition Against Disease. Pitman Publishing.

Saruc M, Standop S, Standop J, Nozawa F, Itami A, Pandey KK, Batra SK, Gonzalez NJ, Guesry P & Pour PM (2004) Pancreatic enzyme extract improves survival in murine pancreatic cancer. Pancreas.28:401-412.

Sebastian P (2006) The Principles of Traditional Practice .pp.17-39.

Ayurvedic Medicine, Churchill Livingstone.

Sharman MJ, Gomez AL, Kraemer WJ & Volek JS (2004) Very low-carbohydrate and low-fat diets affect fasting lipids and postprandial lipidemia differently in overweight men. J Nutr.

Sinatra ST (2003) Lower your bolld pressure in eight weeks. Ballantine Books, New York. pp.49-50.

Tolstoi LG (1992) Osteoporosis—the treatment controversy. Nutrition Today (July’ Aug) 6-12.

Valensi P, Paries J, lormeau B, Attia S & Attali JR (2005) Influence of nutrients on cardiac autonomic function in nondiabetic overweight subjects. Metabolism. 54:1290-1296.

Van Dale, D & Saris WH (1989) Repetitive weight loss and weight regain:

effects on weight reduction, resting metabolic rate, and lipolytic activity before and after exercise and /or diet treatment. AJCN.

49:409-416.

Wannamethee SG, Lowe GD & Shaper AG (2005) The metabolic syndrome and insulin resistance: relationship to haemostatic and inflammatory markers in older non-diabetic men. Atherosclerosis. 181:101-108.

Watson G (1972) Nutrition and Your Mind. Harper and Row

Weston P (1945) Nutrition and Physical Degeneration: A comparison of primitive and modern diets and their effects. La Mesa, CA: Price Pottenger Foundation

Westphal SA (1990) Metabolic response to glucose ingested with various amounts of protein. AJCN. 52:267-272.

WHO Geneva (2000) Obesity: Preventing and managing the global epidemic.

WHO technical reports series 894.

Wiley R (1989) Biobalance. Life Sciences Press

Wolcott W (1983) A theoretical model for clinical application of the

relationship between the autonomic nervous system and the oxidation rate in the determination of metabolic types and the requirements of nutritional individuality. Metabolic technology I. International Health Institute.

Wolcott W (1998) The death of allopathic nutrition. Winthrop, WA:

Healthexcel Publications.

Wolcott W & Fahey T (2000) The Metabolic Typing Diet. New York, Doubleday.

中文部份

行政院衛生署，「肥胖定義及處理委員會」(2001)。離開 BMI 的理想範圍 (BMI 22 上下)，代謝症候群或心血管疾病風險亦隨之增高，離開 越遠風險越高。

李建民，廖育群(2003)。認識印度傳統醫學。東大圖書公司。

陳九如(2006)。黃帝內經今義。國立編譯館主編出版。

林佳儀(2005)。網際網路減重介入之成效探討。北醫公共衛生研究所碩士 論文。

附錄